Cargando…

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol

BACKGROUND: The most commonly applied treatment for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is a 5-day course of high-dose systemic corticosteroids. However, this treatment has not been shown to reduce mortality and can potentially have serious side effects. Recent rese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sivapalan, Pradeesh, Moberg, Mia, Eklöf, Josefin, Janner, Julie, Vestbo, Jørgen, Laub, Rasmus Rude, Browatzki, Andrea, Armbruster, Karin, Wilcke, Jon Torgny, Seersholm, Niels, Weinreich, Ulla Møller, Titlestad, Ingrid Louise, Andreassen, Helle Frost, Ulrik, Charlotte Suppli, Bødtger, Uffe, Nielsen, Thyge Lynghøj, Hansen, Ejvind Frausing, Jensen, Jens Ulrik Stæhr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558695/ https://www.ncbi.nlm.nih.gov/pubmed/28810909 http://dx.doi.org/10.1186/s12890-017-0458-7

Ejemplares similares

Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients
por: Rastoder, Ema, et al.
Publicado: (2021)

Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients
por: Bagge, Kristian, et al.
Publicado: (2021)

Corticosteroid Resistance in Smokers—A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Sedating antihistamine treatment with promethazine in patients with severe COPD with and without asthma: death and severe exacerbations in a nationwide register study
por: Bonnesen, Barbara, et al.
Publicado: (2023)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Treatment Response Biomarkers in Asthma and COPD
por: Meteran, Howraman, et al.
Publicado: (2021)

Automated oxygen control with O2matic(®) during admission with exacerbation of COPD
por: Hansen, Ejvind Frausing, et al.
Publicado: (2018)

Hypoxemia and not hyperoxemia predicts worse outcome in severe COPD exacerbations - an observational study
por: Sandau, Charlotte, et al.
Publicado: (2022)

Depressive symptoms among patients with COPD according to smoking status: a Danish nationwide case–control study of 21 184 patients
por: Vestergaard, Jakob Hedemark, et al.
Publicado: (2020)

The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients
por: Jordan, Alexander, et al.
Publicado: (2021)

Long-term non-invasive ventilation for COPD patients following an exacerbation with acute hypercapnic respiratory failure: a randomized controlled trial
por: Hedsund, Caroline, et al.
Publicado: (2023)

Do telemedical interventions improve quality of life in patients with COPD? A systematic review
por: Gregersen, Thorbjørn L, et al.
Publicado: (2016)

Automated Oxygen Administration Alleviates Dyspnea in Patients Admitted with Acute Exacerbation of COPD: A Randomized Controlled Trial
por: Sandau, Charlotte, et al.
Publicado: (2023)

Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
por: Bonnesen, Barbara, et al.
Publicado: (2022)

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease
por: Eklöf, Josefin, et al.
Publicado: (2022)

Mortality and exacerbations associated with Stenotrophomonas maltophilia in chronic obstructive pulmonary disease. A regional cohort study of 22,689 outpatients
por: Rønn, Christian, et al.
Publicado: (2023)

Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial
por: Eklöf, Josefin, et al.
Publicado: (2022)

Management of COPD in general practice in Denmark – participating in an educational program substantially improves adherence to guidelines
por: Ulrik, Charlotte Suppli, et al.
Publicado: (2010)

Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms
por: Sivapalan, Pradeesh, et al.
Publicado: (2022)

NIV for acute respiratory failure in COPD: high in-hospital mortality is determined by patient selection
por: Hedsund, Caroline, et al.
Publicado: (2019)

Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial Population
por: Kamstrup, Peter, et al.
Publicado: (2022)

Major cardiovascular events in patients with severe COPD with and without asthma: a nationwide cohort study
por: Bonnesen, Barbara, et al.
Publicado: (2022)

Home Non Invasive Ventilation (NIV) treatment for COPD patients with a history of NIV-treated exacerbation; a randomized, controlled, multi-center study
por: Ankjærgaard, Kasper Linde, et al.
Publicado: (2016)

Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020)

Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease
por: Saeed, Mohamad Isam, et al.
Publicado: (2020)

Acute Lung Injury in Critically Ill Patients: Actin-Scavenger Gelsolin Signals Prolonged Respiratory Failure
por: Holm, Freja Stæhr, et al.
Publicado: (2019)

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method
por: Jordan, Alexander, et al.
Publicado: (2023)

Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
por: Bonnesen, Barbara, et al.
Publicado: (2021)

Effect of tele–health care on quality of life in patients with severe COPD: a randomized clinical trial
por: Tupper, Oliver D, et al.
Publicado: (2018)

Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial
por: Kamstrup, Peter, et al.
Publicado: (2023)

High-pressure NIV for acute hypercapnic respiratory failure in COPD: improved survival in a retrospective cohort study
por: Hedsund, Caroline, et al.
Publicado: (2022)

Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
por: Suppli Ulrik, Charlotte
Publicado: (2012)

Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits
por: Mathioudakis, Alexander G, et al.
Publicado: (2020)

Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial
por: Ringbæk, Thomas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u74jonth9gf780sf09om808uh3